Revenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...
Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...
Robotics firms that may deserve a closer look by investors include AeroVironment, Cognex, and Myomo, all of which offer compelling products and tech.
These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025.
Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Earlier this year, US President Joe Biden and his administration put out a new executive order on safe, secure, and...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...